Advertisement
Pharma/Biotech News
Subscribe to Pharma/Biotech News
View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

MRIGlobal Wins $54 Million NIH Neurological Disorders And Stroke Contract

January 16, 2015 11:25 am | News | Comments

MRIGlobal announced that it has been awarded a $54 million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials. Read more...

Scientists Find How Many Cancers May Evade Treatment

January 16, 2015 10:57 am | by University of Wisconsin-Madison | News | Comments

The drugs were designed to keep cancer cells at bay by preventing their growth, survival and spread. Yet, after clinical trials, they left scientists scratching their heads and drug developers watching their investments succumb to cancer’s latest triumph. Read more...

AbbVie Gains European Marketing Authorization for Hepatitis C Drugs

January 16, 2015 9:18 am | News | Comments

The approvals follow a review under accelerated assessment by the European Medicines Agency. Read more...                          

Advertisement

Sanofi, BI Enter Manufacturing Collaboration for Biologics

January 16, 2015 8:48 am | News | Comments

72 percent of Sanofi’s Research and Development projects are in biologics, nearly half of which are monoclonal antibodies (mAbs). Read more...                    

CDC: Flu Vaccine Not Working Well

January 15, 2015 2:07 pm | by Mike Stobbe - AP Medical Writer | News | Comments

The CDC's report explains that this year's vaccine is only 23 percent effective. Read more...                            

Five Biotech Startups to Watch in 2015

January 15, 2015 10:44 am | by Ryan Bushey, Associate Editor | Articles | Comments

These companies are revolutionizing agriculture, genomics, and the drug discovery process. Read more...                          

Alimera Announces First Sale of Iluvien in Portugal

January 15, 2015 8:59 am | News | Comments

Alimera's medication is for the treatment of vision impairment associated with chronic diabetes. Read more...                         

Death Row Inmates Seek Appeal for Drug Protocol Ruling

January 14, 2015 12:47 pm | by Associated Press | News | Comments

Attorneys for four Oklahoma death row inmates are appealing to the U.S. Supreme Court to overturn a 10th Circuit Court ruling that approved the state's execution drug protocol. Read more...            

Advertisement

FDA Approves First of Kind Device for Obesity Treatment

January 14, 2015 12:44 pm | News | Comments

This is the first weight loss treatment device that targets the nerve pathway between the brain and the stomach that controls feelings of hunger and fullness. Read more...              

No Sign of Ebola in CDC Worker Feared Exposed Weeks Ago

January 14, 2015 9:37 am | by Mike Stobbe - AP Medical Writer | News | Comments

Ebola symptoms usually strike within three weeks of infection. Read more...                               

Novartis, Qualcomm Create Investment Company for Digital Health

January 14, 2015 9:28 am | News | Comments

Digital and mobile technologies are expected to make a significant difference in the pharmaceutical industry. Read more...                       

Roche, Meiji and Fedora Team Up to Tackle Bacterial Resistance to Antibiotics

January 14, 2015 9:22 am | News | Comments

The three pharmaceutical companies entered into a license agreement for the development and commercialization of a new inhibitor. Read more...                    

How to Predict Responses to Disease

January 14, 2015 9:12 am | by David L. Chandler - MIT | News | Comments

Computer model could help public health officials anticipate overreactions to disease outbreaks. Read more...                         

Advertisement

Merck Seeks New OK for Cancer Drug, Reorganization on Track

January 13, 2015 12:19 pm | by Linda A. Johnson, AP Business Writer - Associated Press | News | Comments

Drugmaker Merck & Co. is ratcheting up its race with rival Bristol-Myers Squibb Co. for leadership in one of today's hottest research areas, immuno-oncology, which harnesses the immune system to fight cancer. Read more...                        

Prime Therapeutics Strikes Deals to Prefer both Harvoni, Viekira Hepatitis C Drugs

January 13, 2015 12:08 pm | by Prime Therapeutics | News | Comments

People with Hepatitis C who are served by pharmacy benefit manager Prime Therapeutics LLC (Prime) will now have greater support for the treatment recommended by their physician. This is a result of new agreements between Prime and pharmaceutical companies Gilead Sciences and AbbVie. Read more...  

EGFR Inhibitor Extends OS Compared With Chemo

January 13, 2015 11:51 am | by Boehringer Ingelheim | News | Comments

Boehringer Ingelheim announced overall survival (OS) results were published in The Lancet Oncology from two independent Phase 3 clinical trials (LUX-Lung 3 and LUX-Lung 6) in epidermal growth factor receptor (EGFR) mutation-positive patients with metastatic non-small cell lung cancer (NSCLC). Read more...

Researchers Discover Personalized Therapy for Cardiovascular Disease

January 13, 2015 9:09 am | by Montreal Heart Institute | News | Comments

This is a world-first discovery regarding a new medication called dalcetrapid. Read more...                            

FDA Clears Milestone Pharmaceutical's PSVT Drug for Phase 2 Study

January 13, 2015 8:53 am | News | Comments

The drug is for the treatment of acute episodes of Paroxysmal Supraventricular Tachycardia (PSVT). The trial is expected to begin patient enrollment in early 2015. Read more...              

Celator Announces Promising Phase 2 Data for AML Drug

January 12, 2015 12:58 pm | News | Comments

Celator Pharmaceuticals published this data earlier today. Read more...                                

Scientists Find Possible Target for Treating Brain Inflammation

January 12, 2015 12:34 pm | by The Scripps Research Institute | News | Comments

Scientists identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Read more...                         

Amerisourcebergen Expands into Animal Health with $2.5B Deal

January 12, 2015 12:19 pm | by Associated Press | News | Comments

Pharmaceutical distributor AmerisourceBergen will stretch its reach into veterinary medicine by spending about $2.5 billion to acquire MWI Veterinary Supply. Read more...               

UroSens Gets $2M to Commercialize Bladder, Prostate Cancer Test

January 12, 2015 11:21 am | by UroSens | News | Comments

UroSens Ltd, a diagnostic company developing novel, non-invasive urine tests for the detection of prostate and bladder cancer, has announced it has received £2 million ($3.02 million) investment. Read more...                                            

Clementia Pharmaceuticals: New Site for FOP Trial

January 12, 2015 11:15 am | News | Comments

Clementia Pharmaceuticals, Inc. announced the opening of a new site in Paris, France for the Phase 2 clinical trial of palovarotene, the company's lead product candidate for the treatment of fibrodysplasia ossificans progressiva (FOP).  Read more...      

Shire to Buy Specialty Drugmaker NPS Pharma For $5.2B

January 12, 2015 9:27 am | by Associated Press | News | Comments

Irish drugmaker Shire PLC said it will pay $5.2 billion to acquire NPS Pharmaceuticals Inc., which specializes in drugs for rare conditions. Read more...;                                                                 

Regeneron, Sanofi: Positive Results in Hypercholesterolemia Trials

January 9, 2015 11:28 am | by Sanofi | News | Comments

Regeneron Pharmaceuticals, Inc. and Sanofi announced that two new ODYSSEY trials, which are the first Phase 3 trials to assess alirocumab administered every four weeks, met their primary efficacy endpoints. Read more...               

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading